INTERNATIONAL PATENT: NEWAMSTERDAM PHARMA B.V. FILES APPLICATION FOR "OBICETRAPIB FOR THE TREATMENT OF DEMENTIAS"

GENEVA, March 31 -- NEWAMSTERDAM PHARMA B.V. (Gooimeer 2-351411 DC Naarden) filed a patent application (PCT/US2024/047885) for "OBICETRAPIB FOR THE TREATMENT OF DEMENTIAS" on Sep 21, 2024. With publication no. WO/2026/063944, the details related to the patent application was published on Mar 26, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DAVIDSON, Michael, Harvey (c/o NewAmsterdam Pharma B.V.Gooimeer 2-351411 DC Naarden), KASTELEIN, Johannes, Jacob Pieter (c/o NewAmsterdam Pharma B.V.Gooimeer 2-351411 DC Naarden), DITMARSCH, Marc (c/o NewAmsterdam Pharma B.V.Gooimeer 2-351411 DC Naarden...